FDA Letter API

Anna Health, LLC

Letter data

Company
Anna Health, LLC
Recipient
Mr. Tin Huynh | Owner | Anna Health, LLC | 9724 N Armenia Avenue | Suite 400 | Tampa | , | FL | 33612-7550 | United States
Issue date
2022-04-04
Posted date
Not available
FDA office
Division of Human and Animal Food Operations East IV
Subject
Not available
Product
Dietary Supplements
CMS ID
613294
Reference number
22-HAFE4-WLCOL-07
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Anna Health, LLC MARCS-CMS 613294 — April 04, 2022 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Electronic Email Reference #: 22-HAFE4-WLCOL-07 Product: Dietary Supplements Recipient: Recipient Name Mr. Tin Huynh Recipient Title Owner Anna Health, LLC 9724 N Armenia Avenue Suite 400 Tampa , FL 33612-7550 United States Issuing Office: Division of Human and Animal Food Operations East IV United States Dear Mr. Huynh: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter 21-HAFE4-WL-03 dated March 16, 2021. It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Kind regards, /S/ Pearl Lopina Director of Compliance Branch OHAFO East Division IV Content current as of: 04/08/2022 Regulated Product(s) Dietary Supplements